Ysios Capital

All figures cover the European funds tracked here since 1 January 2025, whether closed or still raising, and are compiled from public sources.

Tracked funds

1

Reported volume

€71m

Latest public closing

1 Mar 2026

Reported volume sums the public fund amounts tracked here, not the manager's firm-wide assets under management, so it may differ from totals on the manager's website.

Ysios Capital is a Barcelona-based life sciences venture capital firm investing globally in biotech ventures developing innovative therapeutics.

Focus: Global biotech ventures developing innovative therapeutic drugs, especially for areas of high unmet medical need.